Drugs News and Research

RSS

UNC team provides first example of successful radiomitigation in mammals

While radiation has therapeutic uses, too much radiation is damaging to cells. The most important acute side effect of radiation poisoning is damage to the bone marrow. The bone marrow produces all the normal blood cells, and therefore a high dose of radiation can lead to low blood counts of red cells, platelets and white blood cells.

24 Jun 2010

Study recommends women to avoid drug abuse during prenatal and breastfeeding periods

Give up smoking, do not drink more than three cups of coffee per day, do not take any kind of drug, or if you do, take it as long as possible before feeding your baby. These are some of the recommendations contained in a study produced by Spanish researchers on methods for detecting medicines and drugs in breast milk. The study shows that the risk from substances such as alcohol is still not well understood.

24 Jun 2010

FDA grants t2cure orphan drug designation for t2c001 in Buerger's Disease

t2cure GmbH, a biopharmaceutical company developing and marketing stem cell-based regenerative therapies, announced today that the FDA has granted orphan drug designation to t2c001 for the treatment of Buerger's Disease. The Company also announced that in a concurrent application in Europe the EMA's Committee for Orphan Medicinal Products recently recommended t2c001 for orphan designation to the European Commission.

24 Jun 2010

AVEO receives EMA orphan medicinal product designation for tivozanib

AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced it has received orphan medicinal product designation for tivozanib (N-{2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl) urea hydrochloride monohydrate), its oral, triple VEGF receptor inhibitor, for the treatment of renal cell carcinoma by the European Medicines Agency (EMA).

24 Jun 2010

Scientists identify promising candidates in natural products that prevent cancer

Exciting headlines about the cancer-preventing potential of berries, red wine, and other foods are in the news almost every day. An article in the current issue of Chemical & Engineering News, ACS' weekly newsmagazine, highlights the researchers trying to make medicines based on substances in those foods and turn their potential into reality.

24 Jun 2010

Cancer Research UK launches new cutting-edge research centre at Imperial

A new cutting-edge cancer centre dedicated to robotic surgery, cancer imaging and drug discovery is launched today, putting London at the forefront of cancer research.

24 Jun 2010

Increased drug development cost drives pharma companies to seek better opportunities in emerging markets

The increased cost of drug development has impelled pharmaceutical companies to seek better opportunities in emerging markets to successfully expand and sell their products. Most pharmaceutical companies consider emerging markets lucrative due to their economical infrastructure and manpower costs and a significant untapped market potential with a large population.

24 Jun 2010

nContact reports results of physician-initiated Convergent Procedure study of AF

nContact Surgical, Inc. reports with interest today the results of a physician-initiated study of the Convergent Procedure that, for the first time, measured the progress of persistent atrial fibrillation (AF) patients at one-year and six-month intervals. Results of the study, which were presented at the 2010 International Society of Minimally Invasive Cardiac Surgeons meeting in Berlin, Germany, indicated that after one year 80% of patients were in sinus rhythm and off anti-arrhythmic medication as a result of the closed chest, multi-disciplinary AF procedure.

24 Jun 2010

June issue of Clinic Women's HealthSource provides overview of anemia

Anemia is not a normal part of aging, yet it's fairly common in older adults and causes frailness, weakness and increased risk of falls. According to Mayo Clinic Women's HealthSource, more than one in 10 older adults has anemia. Twenty percent of women are anemic by age 85.

24 Jun 2010

Alnylam presents data on novel delivery lipids at IBC 6th Annual Cell Line Development and Engineering conference

Alnylam Biotherapeutics, a division of Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today the presentation of new data at the IBC 6th Annual Cell Line Development and Engineering conference held in San Francisco, California from June 21 - 24, 2010.

24 Jun 2010

UCSD researchers awarded $2.5M CIRM grant to explore stem cells

A pair of University of California San Diego researchers - Martin Marsala, a specialist in spinal cord trauma and disorders, and Yang Xu, an immunologist - have been awarded more than $2.5 million in new grants from the California Institute for Regenerative Medicine.

24 Jun 2010

Mutation in ion channel that changes its dynamics is implicated in epilepsy: Scientists

In 2004, Washington University in St. Lous researcher Jianmin Cui was handed a puzzling clue to the structure of an ion channel his lab had been studying for five years.

24 Jun 2010

Affiliations with drug-using peers leads to genetic vulnerability towards regular substance use: Study

The nature-nurture debate is usually about how much of something is due to our genes and how much is caused by our environment. New research just published in the academic journal Addiction shows that the case is more interesting for young women who smoke, drink, or use drugs, for two related reasons.

24 Jun 2010

DMARDs should be used early and aggressively at the first sign of RA: Researchers

Disease-modifying antirheumatic drugs should be used early and aggressively at the first sign of rheumatoid arthritis. The results of an 11-year trial, published in BioMed Central's open access journal Arthritis Research & Therapy, demonstrate that active treatment from the very beginning pays off, even in the long run.

24 Jun 2010

Spherix to explore triglycerides for D-tagatose therapy

Spherix Incorporated, an innovator in biotechnology for diabetes therapy, and a provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies, today announced that it will explore triglycerides as a potential therapeutic opportunity for its D-tagatose therapy, pending a review of data from a Phase 3 clinical trial the Company is conducting on the use of D-tagatose as a treatment for Type 2 diabetes.

24 Jun 2010

New poll illustrates difficult situations cancer patients face in affording needed health care

A new poll illustrates the difficulty that cancer patients, survivors and their families face in affording needed health care and paying for other basic necessities such as food and heat, underscoring the need to strongly implement the Affordable Care Act so that it works for people with cancer.

24 Jun 2010

Carvedilol drug may lessen degenerative impact of Alzheimer's disease: Researchers

Researchers at Mount Sinai School of Medicine have found that the drug carvedilol, currently prescribed for the treatment of hypertension, may lessen the degenerative impact of Alzheimer's disease and promote healthy memory functions. The new findings are published in two studies in the current issues of Neurobiology of Aging and the Journal of Alzheimer's Disease.

24 Jun 2010

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

Isotechnika Pharma Inc. today announced that the U.S. Food and Drug Administration (FDA) has cancelled the Dermatology and Ophthalmology Drugs Advisory Committee review of partner, Lux Biosciences', New Drug Application (NDA) for voclosporin on June 28, 2010.

24 Jun 2010

Wellpartner agrees to provide patients access to low-cost medications using 340B Access Solution

Wellpartner, a nationally recognized provider of pharmacy distribution services, today announced an agreement with Community Health Center La Clinica and Custom Prescription Shoppe Pharmacy to provide patients access to low-cost medications using Wellpartner's 340B Access Solution. The agreement will allow patients who qualify to purchase deeply-discounted prescription medications at Community Health Center La Clinica's newly established in-house pharmacy as well as through a network of retail pharmacies in the area.

24 Jun 2010

Parenting style strongly affects teens when it comes to heavy drinking: Study

Parents may be surprised, even disappointed, to find out they don't influence whether their teen tries alcohol. But now for some good news: Parenting style strongly and directly affects teens when it comes to heavy drinking - defined as having five or more drinks in a row - according to a new Brigham Young University study.

24 Jun 2010

Drugs News and Research

UNC team provides first example of successful radiomitigation in mammals

Study recommends women to avoid drug abuse during prenatal and breastfeeding periods

FDA grants t2cure orphan drug designation for t2c001 in Buerger's Disease

AVEO receives EMA orphan medicinal product designation for tivozanib

Scientists identify promising candidates in natural products that prevent cancer

Cancer Research UK launches new cutting-edge research centre at Imperial

Increased drug development cost drives pharma companies to seek better opportunities in emerging markets

nContact reports results of physician-initiated Convergent Procedure study of AF

June issue of Clinic Women's HealthSource provides overview of anemia

Alnylam presents data on novel delivery lipids at IBC 6th Annual Cell Line Development and Engineering conference

UCSD researchers awarded $2.5M CIRM grant to explore stem cells

Mutation in ion channel that changes its dynamics is implicated in epilepsy: Scientists

Affiliations with drug-using peers leads to genetic vulnerability towards regular substance use: Study

DMARDs should be used early and aggressively at the first sign of RA: Researchers

Spherix to explore triglycerides for D-tagatose therapy

New poll illustrates difficult situations cancer patients face in affording needed health care

Carvedilol drug may lessen degenerative impact of Alzheimer's disease: Researchers

FDA cancels Advisory Committee review of Lux Biosciences' voclosporin NDA

Wellpartner agrees to provide patients access to low-cost medications using 340B Access Solution

Parenting style strongly affects teens when it comes to heavy drinking: Study

Drug Discovery - Second Edition eBook

Revolutionizing Life Science: An Interview with SCIEX on ASMS, the SCIEX 7500+ System, and AI-Driven Quantitation

From Discovery Biology to ELRIG Chair

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Latest News